$48.76
+0.63(1.31%)
Mkt Cap $3.6B
$18.65
$48.82
52-Week Range
At A Glance
1
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating disease...
2
Revenue is primarily driven by Product (95%) and Collaboration (5%).
3
Most recently: . Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective J (2026-01-14).
$3.6B
Market Cap
$678M
Revenue
$59M
Net Income
Employees315
Fundamentals
How The Business Makes Money
Revenue by Segment
Product95%($2.7B)
Collaboration5%($139M)
Revenue by Geography
US99.8%($1.4B)
GB0.2%($2M)
Outside United States And United Kingdom0.1%($875.0K)
Activity
What Changed Recently
Company Profile
CIK0001730430
ISINGB00BRXB0C07
CUSIPG5269C101
Phone7814399100
AddressClarendon House, Hamilton, HM 11, BM
SEC EDGAR